Geriatric nutritional risk index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis
Y Mochizuka, Y Suzuki, M Kono, H Hasegawa… - …, 2023 - Wiley Online Library
Abstract Background and Objective Idiopathic pulmonary fibrosis (IPF) is characterized by
progressive lung fibrosis of unknown aetiology. Epidemiological studies have suggested …
progressive lung fibrosis of unknown aetiology. Epidemiological studies have suggested …
Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients
S Jouneau, C Rousseau, M Lederlin, A Lescoat… - Clinical Nutrition, 2022 - Elsevier
Introduction and aims Malnutrition is frequent in patients with idiopathic pulmonary fibrosis
(IPF). We examined the relationship between malnutrition at diagnosis and all-cause …
(IPF). We examined the relationship between malnutrition at diagnosis and all-cause …
The clinical significance of body weight loss in idiopathic pulmonary fibrosis patients
Y Nakatsuka, T Handa, M Kokosi, K Tanizawa… - Respiration, 2018 - karger.com
Background: The significance of the nutritional status in idiopathic pulmonary fibrosis (IPF) is
largely unknown. Temporal body weight (BW) change, a dynamic index of nutrition status …
largely unknown. Temporal body weight (BW) change, a dynamic index of nutrition status …
Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis
Purpose Although safety and tolerability of approved antifibrotics has been reported
extensively, little is known about their effects on weight. We analyzed predictors of weight …
extensively, little is known about their effects on weight. We analyzed predictors of weight …
What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center
S Jouneau, M Kerjouan, C Rousseau, M Lederlin… - Nutrition, 2019 - Elsevier
Objectives Little is known about the indicators to assess malnutrition in patients with
idiopathic pulmonary fibrosis (IPF). This study aimed to determine the following: 1) the …
idiopathic pulmonary fibrosis (IPF). This study aimed to determine the following: 1) the …
Association between weight loss and mortality in idiopathic pulmonary fibrosis
A Kalininskiy, AR Rackow, D Nagel, D Croft… - Respiratory …, 2022 - Springer
Rationale Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung
disease that has no cure. Many current research efforts center on diagnostic and therapeutic …
disease that has no cure. Many current research efforts center on diagnostic and therapeutic …
Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone
TH Kim, YY Shin, HJ Kim, MJ Song, YW Kim, SY Lim… - Scientific Reports, 2022 - nature.com
There have been limited studies on the association between prognosis and body weight
change in patients with idiopathic pulmonary fibrosis (IPF). This single-center retrospective …
change in patients with idiopathic pulmonary fibrosis (IPF). This single-center retrospective …
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study
P Faverio, A Fumagalli, S Conti, F Madotto… - ERJ Open …, 2022 - Eur Respiratory Soc
Background Nutritional status impacts quality of life and prognosis of patients with
respiratory diseases, including idiopathic pulmonary fibrosis (IPF). However, there is a lack …
respiratory diseases, including idiopathic pulmonary fibrosis (IPF). However, there is a lack …
Clinical impact of weight loss on mortality in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
JK Lee, C Chung, J Kim, HS Cho, HC Kim - Scientific Reports, 2023 - nature.com
Patients with idiopathic pulmonary fibrosis (IPF) often experience weight loss during the
follow-up period. However, the prevalence and clinical impact of weight loss in these …
follow-up period. However, the prevalence and clinical impact of weight loss in these …
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy
Y Suzuki, Y Aono, M Kono, H Hasegawa… - …, 2021 - Wiley Online Library
Background and objective Recent research has highlighted the fundamental role of
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …
相关搜索
- mortality risk antifibrotic therapy
- sarcopenia in patients antifibrotic therapy
- weight loss mortality in patients
- critical issues analysis nutrition in patients
- sarcopenia in patients cause of mortality
- fibrosis patients referral center
- clinical impact mortality in patients
- fibrosis patients food intake
- fibrosis patients clinical significance
- cause of mortality antifibrotic therapy